599 filings
424B3
PRTG
Portage Biotech Inc
30 Apr 24
Prospectus supplement
6:23pm
6-K
PRTG
Portage Biotech Inc
30 Apr 24
Current report (foreign)
6:21pm
424B3
PRTG
Portage Biotech Inc
12 Apr 24
Prospectus supplement
5:22pm
6-K
PRTG
Portage Biotech Inc
12 Apr 24
Portage Biotech Announces Plans to Expand its Evaluation of Strategic Alternatives
5:21pm
424B3
PRTG
Portage Biotech Inc
8 Mar 24
Prospectus supplement
5:30pm
6-K
qx2ddpzoowc13cxdulj
8 Mar 24
Current report (foreign)
5:04pm
424B3
fgrkrugs3pr
6 Mar 24
Prospectus supplement
9:36pm
6-K
a3taz 39e2k
6 Mar 24
Current report (foreign)
9:11pm
6-K
zgod nngfp0
28 Feb 24
Company focused on adenosine platform clinical development
6:42pm
424B3
cdhamc
28 Feb 24
Prospectus supplement
5:19pm
6-K
okb5dwe
28 Feb 24
Current report (foreign)
5:17pm
SC 13G
tm4w1usksfbr
14 Feb 24
PORTAGE BIOTECH / ARMISTICE CAPITAL ownership change
3:50pm
424B3
kaavsca
18 Jan 24
Prospectus supplement
5:41pm
6-K
12l 66jtisto
18 Jan 24
Current report (foreign)
5:09pm
424B3
us02ty9 p6jdqjq
4 Jan 24
Prospectus supplement
5:49pm
6-K
odl 16j27v27z8dwq04
4 Jan 24
Current report (foreign)
8:10am
S-8
dvt9fb
1 Dec 23
Registration of securities for employees
4:05pm
424B3
9zf jib6a4h
28 Nov 23
Prospectus supplement
4:03pm
6-K
x6g ehia0nd5x9nilgj
28 Nov 23
PORT 2 and 6 Presented at the Society for Immunotherapy of Cancer’s (SITC) Annual Meeting
4:02pm
6-K
bte571
28 Nov 23
Current report (foreign)
4:01pm